OUR MISSION:
To provide the hospital industry with clinical benefits to the patient and economic advantages
to the hospital through implementation of best practices blood management programs.

History

History
F. Curtis Lambert, PhD, President, and CEO of Infonalé, began his healthcare career with IBM in information technology at White Plains, NY in 1969. Dr. Lambert demonstrated skill in sales and marketing, especially in international arenas. He had the ability to turn around critical situations dealing with technical, financial, strategic and marketing issues.  Later, he held national and international positions with Shared Medical Services (SMS) and while living abroad, he was able to study the healthcare systems in Germany, England, Ireland, Holland, and Japan, as well as the United States.

Always interested in the field of blood conservation, Dr. Lambert kept up with the latest in alternatives for blood transfusion. A chance meeting with Dr. Richard K. Spence, also passionate in this area of medicine, turned into a lifelong friendship. The two realized that their personal missions were very similar, and they began to investigate the concept and advantages of hospital-wide blood management.

After a long and successful career in hospital information services with SMS, Dr. Lambert founded Medical Management Consultants International, Inc., a not-for-profit corporation, and designed a totally new solution for the hospital industry: first provide actual on-site clinical expertise to enhance clinical practices, and then utilize specifically specialized technology to track clinical, financial and patient outcomes.  The results speak for themselves . . . restoration of fiscal viability with improved patient outcomes.

As a result of these experiences and his collaboration with physicians around the world, Dr. Lambert founded Infonalé, Inc. in 2002 and continued to develop what is now called PORis™ (Patient Outcomes Registry information system). Infonalé was founded as an information and change management company specializing in Clinical Management.

Infonalé’s PORis™ was installed into two beta sites in large hospitals in northeast United States utilizing different reimbursement systems, where it was refined in real-world hospital settings. It has continued to evolve over the past six years and now contains over 25 years of hospital data. It has the ability to generate key reports vital for the day-to-day care of the patient, as well as to clinical and financial administrators and corporate executives.

PORis™ has the proven ability to consolidate and track essential data and metrics from pre-admission to post-discharge. By means of PORis™, Infonalé can provide reporting capabilities specific to blood management that hospitals have not been able to generate or duplicate unless they do it through individual and time consuming chart-by-chart review.

The Infonalé Team
Talented people make a major difference and contribution at Infonalé. The goal of the company is to provide solutions for the healthcare industry through clinical and blood management. Each member of the Infonalé team brings a particular background and quality of work experience that compliments the rest of the team. Collectively, they have over a hundred years of expertise in the specialized field of blood management alone.

Infonalé’s team includes physicians, nurse consultants, customer service and marketing specialists. Industry representation is across the board: years of experience in healthcare information technology, science and research, hospital law and administration, and finance. The company works with numerous healthcare experts as required, creating an unbeatable combination.

Richard K. Spence, MD, MHA, FACS accepted the position of Infonalé’s Senior Vice President of Clinical Affairs. He is known around the world for his expertise in the fields of blood management and surgical education and leads the Infonalé clinical team.  Dr. Spence has written over 250 articles for leading medical journals on this topic.  He has been invited to speak at seminars on blood management all over the world. He is the co-founder of both the Network for the Advancement of Transfusion Alternatives (NATA) and the Society for the Advancement of Blood Management (SABM), and a founding board member of the Medical Society for Blood Management (headquartered in Austria).

Jack Henn, MBA, serves as Infonalé's Sales and Marketing Director. He is a graduate of Princeton University with a degree in chemical engineering and holds a Masters in Business Administration from Harvard Business School. Mr. Henn has made a career of business development activities that include leadership responsibilities for rapid-growth organizations through new product introductions, partnerships, mergers and acquisitions.

John C.S. Kepner serves on Infonalé's advisory team. He has over thirty years of consulting experience, including executive management roles with prominent academic health systems, business and health care practice and leadership positions with a large mid-Atlantic regional law firm.                               

Infonalé places emphasis on industry leadership. It has actively pursued strategic relationships to leverage its industry development capabilities. Infonalé has ongoing relationships with several pharmaceutical companies, a large national hospital supply chain firm, and several world-renowned blood management associations.

Infonalé has the right team in place to be recognized as the world leader in blood management strategies.

“Bloodless Medicine and Surgery Center” Market is Changing
The “bloodless medicine and surgery center” market is rapidly changing to hospital-wide blood management.  Economics are forcing changes in health care.  Major hospital departments are consolidating.  The most seasoned management positions are playing “musical chairs” or “Russian Roulette” knowing their upper management must thin out expenses. Only the most productive leaders of the seasoned managers at “bloodless centers” will survive.  Accomplishment will be the only measurement for continued tenure: “What have you done for me lately.” “How well can you prove the return on investment / net worth of your departmental expense?” 

Traditional “Bloodless Medicine and Surgery Centers” were attractive to administrations when they were competing for patient share.  Since occupancy rates are very high due to the baby-boomer impact on health care, patients will go where they are told by insurance carriers and where they can be served quickly.  New Market capture is no longer the key to survival; it is cost cutting, with revenue/gain sharing to those who perform with well-documented quality outcomes.

Infonalé becomes the means to make major clinical and fiscal improvements.  The hospital executive provides the leadership and direction, and expectations, while Infonalé provides the benchmarks using proprietary blood management tools and continues to monitor the program.  Major cost cutting opportunities, which are well documented and medically justified, are the only way to prove the coordinator’s net worth and retain tenure in the current market.  

Today
Infonalé Inc. is fast becoming the recognized world leader in blood management strategies, with the capacity to capture information that most hospitals are not able to report or analyze. Infonalé’s reports are accurate, specific and valuable to all physicians, nurses, and hospital administrators.

The company's proprietary technology, PORis™, has the metrics unique to blood management established on evidence-based medicine. Dr. Lambert has spent the last six years testing, collecting, and fine tuning PORis™ to make it state-of-the-art in the field.

Infonalé addresses your entire hospital structure in a systematic way to increase patient safety and reduce cost throughout the whole hospital. Over the past three years Infonalé has accelerated its product innovation and development activities. The result is an added tracking tool for Nosocomial Infection and a Quality of Life (QoL) patient survey to validate improved patient outcomes. These innovations provide a new platform on which the company's accelerated growth is firmly based.

In July 2007, Haemonetics Corporation, the global leader in blood management solutions, acquired Infonalé, Inc. to complement its expanding portfolio into hospital surgical markets. Haemonetics is committed to bring to its blood collection and hospital customers a suite of blood management solutions that can reduce costs and improve clinical outcomes. Infonalé's proprietary software, clinical database, and consulting services support this vision.

Let Infonalé become your resource. Our years of experience cover all aspects of the healthcare industry. Let Infonalé assist you in doing the work needed to establish your own successful hospital-wide blood management program and improve physician practice patterns, patient safety and reduce costs.